Reviewed by the PeptideMind Team · Updated August 5, 2026
Mazdutide Peptide Dosage Guide, Benefits & Side Effects
Mazdutide (IBI-362) peptide dosage guide with our calculator: dual GLP-1/GCGR agonist approved in China for major weight loss, plus benefits, side effects & safety data.
Mazdutide Dosage Schedule
A once weekly protocol studied for reducing appetite and helping the body burn more energy, with added benefits for blood sugar control in type 2 diabetes. Best suited for a longer, multi month commitment.
Mazdutide for Weight Loss and Blood Sugar Control
18 weeks, focused on weight management.
1 days per week
Taken Sunday.
6 mg per injection
6 mg per injection, given just under the skin in the abdomen or thigh.
Mazdutide is an experimental injection being studied for weight loss and blood sugar control in type 2 diabetes. It works by curbing appetite and helping your body burn more energy.
What is Mazdutide?
Mazdutide is a lab-made injectable compound that acts on two different appetite and metabolism pathways at once. It helps reduce hunger, increases how many calories your body burns, and improves blood sugar control. It's approved in China for weight management and type 2 diabetes, though it isn't approved in the US and remains experimental outside China.
Weight
maz
Metabolic
Our top-rated vendor
Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing, no paid placements, no affiliate influence. We update this list as new data comes in.
Based on current scores, this vendor ranks highest across those criteria.
What Does Mazdutide Do?
It activates two separate hormone receptors at once: one dials down appetite and slows digestion, while the other ramps up how many calories the body burns and how much fat the liver processes. It also appears to ease a form of cellular stress in the liver that's linked to fat buildup and inflammation.
Two receptors at once
Activates two separate hormone receptors simultaneously.
Curbs appetite
One receptor dials down appetite and slows digestion.
Burns more calories
The other raises calorie burn and eases liver-related cellular stress.
Mazdutide Targeted areas
Frequently Asked Questions About Mazdutide
Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.
Mazdutide Reconstitution Guide
Mazdutide is supplied as a freeze-dried powder that must be mixed into a injectable solution before use. Available in 5mg, 6mg, 10mg sizes.
5 mg lyophilized vial
Mazdutide is supplied as a freeze-dried powder that must be mixed into a injectable solution before use. Available in 5mg, 6mg, 10mg sizes.
2 mL bacteriostatic water
Adding 2 mL of bac water to a 5 mg vial gives a workable concentration for syringe dosing. More water makes microdosing easier; less concentrates each draw.
Storage after mixing
Freeze the dry powder — up to a year in a regular freezer or two years in a deep freezer — sealed away from moisture and light. Once mixed with liquid, refrigerate it and avoid freezing and thawing it repeatedly. After reconstitution, keep the vial refrigerated and use within 30 days.
Reconstitution steps
Remove caps & sanitize stoppers
Attach needle to syringe
Draw 2 mL bacteriostatic water
Insert needle into Mazdutide vial
Release water gently down the side
Swirl to dissolve — don't shake
Check for full dissolution
Refrigerate Mazdutide — good for 30 days
Chemical Makeup
31
Amino Acids
Mazdutide
Ala
APosition 1
Met
MPosition 2
Ile
IPosition 3
Asn
NPosition 4
Pyl
OPosition 5
Ala
APosition 6
Cys
CPosition 7
Ile
IPosition 8
Asp
DPosition 9
Leu
LPosition 10
Ile
IPosition 11
Asn
NPosition 12
Glu
EPosition 13
Ala
APosition 14
Arg
RPosition 15
Ser
SPosition 16
Tyr
YPosition 17
Asn
NPosition 18
Thr
TPosition 19
His
HPosition 20
Glu
EPosition 21
Thr
TPosition 22
Ile
IPosition 23
Cys
CPosition 24
Pro
PPosition 25
Glu
EPosition 26
Pro
PPosition 27
Thr
TPosition 28
Ile
IPosition 29
Asp
DPosition 30
Glu
EPosition 31
What Are the Benefits of Mazdutide?
What research says it may help with, and how it works in the body.
weight loss
Led to meaningful improvements in waist size, blood pressure (down about 7.6 points), and blood fat levels called triglycerides (down 43%).
Early analysis found an 80% drop in liver fat, suggesting it may help with fatty liver disease.
In the GLORY-2 clinical trial, a 9mg dose led to an average weight loss of 20.1% over 60 weeks, and almost half of participants lost 20% or more of their body weight.
type 2 diabetes
Lowered long-term blood sugar levels (measured by a marker called HbA1c) by 1.4-2.0 percentage points across trials, slightly outperforming semaglutide (a similar diabetes/weight-loss drug) in one trial.
48% of people reached both a healthy blood sugar target and lost at least 10% of their body weight, compared to only 21% of those on semaglutide (a similar diabetes/weight-loss drug).
cardiovascular
In clinical trials, it lowered the top blood pressure number by about 7.6 points and the bottom number by about 3 points.
Reduced total cholesterol by about 17%, blood fats (triglycerides) by about 43%, and LDL ("bad" cholesterol) by about 17%.
What Are the Side Effects of Mazdutide?
Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds.
Who Should Avoid It
Personal or family history of medullary thyroid carcinoma
MEN2 syndrome history (class warning for GLP-1 agonists)
Pregnancy or breastfeeding (insufficient safety data)
Stop Right Away If You Notice
Severe or persistent abdominal pain (potential pancreatitis)
Neck lumps, hoarseness, or difficulty swallowing
Severe nausea/vomiting preventing adequate nutrition or hydration
Signs of severe hypoglycemia (confusion, sweating, shakiness)
Severe allergic reactions (rash, difficulty breathing, facial swelling)
Unusual mood changes, depression, or suicidal thoughts
Signs of gallbladder problems (severe upper right abdominal pain)
Milder Signs to Watch For
Is Mazdutide FDA approved?
Mazdutide is not an FDA-approved drug. It is intended for research purposes only and is not approved for human consumption, diagnostic, or therapeutic use.
Research Use Only
Mazdutide has not been evaluated by the FDA for safety or efficacy in humans.
No Clinical Oversight
Not manufactured under FDA-regulated quality or clinical standards.
Unregulated Sourcing
Purity, dosing, and sourcing are not verified through FDA testing or oversight.

Mazdutide Cycle Length: How Long Should It Last?
This breaks down how long a typical Mazdutide cycle runs and what research suggests happens at each stage. Research shows that staying on a peptide continuously, without a break, may make it less effective over time.
That's why most research protocols build in a break between cycles, often called a washout period, to let the body reset before starting again.
- Week 1-2
- Appetite reduction, possible mild nausea, decreased portion sizes
- Week 3-4
- Early weight loss begins (1-2%), improved satiety after meals
- Week 4-8
- Dose escalation phase, GI symptoms typically improving, 3-5% weight loss
- Week 8-16
- Steady weight loss continues (7-12%), energy expenditure effects evident
- Week 16-32
- Significant weight reduction (12-17%), metabolic markers improving
- Week 32-60
- Peak effects (up to 20% weight loss), sustained improvements in BP, lipids, glucose
Mazdutide Research References
It is an approved compound
Mazdutide
Mazdutide is an approved compound
610 Chinese adults with obesity/overweight; 48 weeks. First Phase 3 weight management trial showing clinically meaningful weight reductions. NEJM.
2025
349 Chinese adults with T2D and obesity; 32 weeks. Mazdutide superiority: 48% vs 21% achieved HbA1c <7.0% AND ≥10% weight reduction (p<0.0001).
2025
Chinese adults with T2D; 20 weeks. HbA1c reductions 1.41-1.67% vs 0.03% placebo; weight loss up to 7.1%. Diabetes Care.
2024
462 Chinese adults with obesity; 60 weeks; 9mg dose. 20.1% weight loss vs 2.8% placebo; 48.7% achieved ≥20% reduction; no plateau observed.
2025
